Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastoma
H. G. Anderson, G. P. Takacs, D. C. Harris, Y. Kuang, J. K. Harrison, T. L. Stepien
This paper develops a tumor-immune model for glioblastoma, identifies key parameters for treatment, and suggests combining immune checkpoint inhibitors with MDSC-targeting therapies.
bioRxiv · May 15, 2023Cancer Biology